A randomised controlled clinical trial comparing pure Portland cement and formocresol pulpotomies followed from 2 to 4 years.
Formocresol
Medcem-MTA®
Primary molars
Pulpotomy
Journal
European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry
ISSN: 1996-9805
Titre abrégé: Eur Arch Paediatr Dent
Pays: England
ID NLM: 101277157
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
05
07
2020
accepted:
21
10
2020
pubmed:
12
11
2020
medline:
28
7
2021
entrez:
11
11
2020
Statut:
ppublish
Résumé
The purpose of the present prospective randomised clinical control trial was to evaluate the long-term clinical and radiographic success rate of pulpotomies in primary molars using pure Portland cement versus formocresol. Pure Portland cement has shown a high rate of success in pulpotomy treatments, with no side effects. Healthy 3- to 11-year-old children were treated with pulpotomies on primary molars as part of their scheduled dental treatment. Pulp dressing alternated randomly between pure Portland cement and formocresol. Data were analysed at follow-up periods up to 48 months. 68 (50%) teeth with pure Portland cement and 68 (50%) teeth with formocresol in 136 healthy children (59 boys and 77 girls) were followed. The overall success rate of the pulpotomies in this study was 95.6%. Pure Portland cement was successful in 100% of the cases (68 out of 68), and formocresol in 91.1% (62 out of 68). No association was found between success and type of tooth or time range from treatment to last follow-up. Based on this study's results, it can be concluded that there is no superiority of one material over the other and pure Portland cement can be used in primary molar pulpotomies.
Identifiants
pubmed: 33175326
doi: 10.1007/s40368-020-00578-y
pii: 10.1007/s40368-020-00578-y
doi:
Substances chimiques
Calcium Compounds
0
Drug Combinations
0
Formocresols
0
Silicates
0
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
547-552Informations de copyright
© 2020. European Academy of Paediatric Dentistry.
Références
Arora V, Nikhil V, Sharma N, Arora P. Bioactive dentin replacement. IOSR J Dent Med Sci. 2013;12(4):51–7.
doi: 10.9790/0853-1245157
Bonson S, Jeansonne BG, Lallier TE. Root-end filling materials alter fibroblast differentiation. J Dent Res. 2004;83(5):408–13.
doi: 10.1177/154405910408300511
Coll JA, Seale NS, Vargas K, Marghalani AA, Al Shamali S, Graham L. Primary tooth vital pulp therapy: a systematic review and meta-analysis. Pediatr Dent. 2017;39(1):16–123.
pubmed: 28292337
Conti TR, Sakai VT, Fornetti APC, Moretti ABS, Oliveira TM, Lourenco Neto N, Machado MAAM, Abdo RCC. Pulpotomies with Portland cement in human primary molars. J Appl Oral Sci. 2009;17(1):66–9.
doi: 10.1590/S1678-77572009000100013
Dhar V, Marghalani AA, Crystal YO, et al. Use of vital pulp therapies in primary teeth with deep caries lesions. Pediatr Dent. 2017;39(5):146–59.
pubmed: 29070150
Fuks AB. Vital pulp therapy with new materials for primary teeth: new directions and treatment perspectives. Pediatr Dent. 2008;30(3):211–9.
pubmed: 18615986
Junqueira MA, Cunha NNO, Caixeta FF, et al. Clinical, radiographic and histological evaluation of primary teeth pulpotomy using MTA and ferric sulfate. Braz Dent J. 2018;29(2):159–65.
doi: 10.1590/0103-6440201801659
Lin PY, Chen HS, Wang YH, Tu YK. Primary molar pulpotomy: a systematic review and network meta-analysis. J Dent. 2014;42(9):1060–77.
doi: 10.1016/j.jdent.2014.02.001
Marques N, Lourenço Neto N, Fernandes AP, et al. Pulp tissue response to Portland cement associated with different radio pacifying agents on pulpotomy of human primary molars. J Microsc. 2015;260(3):281–6.
doi: 10.1111/jmi.12294
Priyalakshmi S, Manish R. Review on biodentine: a bioactive dentin substitute. IOSR J Dent Med Sci. 2014;13(1):13–7.
Rajasekharan S, Martens LC, Vandenbulcke J, Jacquet W, Bottenberg P, Cauwels RGEC. Efficacy of three different pulpotomy agents in primary molars: a randomized control trial. Int Endod J. 2017;50(3):215–28.
doi: 10.1111/iej.12619
Rezende TM, Vargas DL, Cardoso FP, Sobrinho AP, Vieira LQ. Effect of mineral trioxide aggregate on cytokine production by peritoneal macrophages. Int Endod J. 2005;38(12):896–903.
doi: 10.1111/j.1365-2591.2005.01036.x
Sakai VT, Moretti ABS, Oliveira TM, Fornetti APC, Santos CF, Machado MAAM, Abdo RCC. Pulpotomy of human primary molars with MTA and Portland cement: a randomised controlled trial. Br Dental J. 2009;207:E5.
doi: 10.1038/sj.bdj.2009.665
Sealed Envelope Ltd. Power calculator for binary outcome non-inferiority trial; 2012. https://www.sealedenvelope.com/power/binary-noninferior/ . Accessed 19 Nov 2019.
Smaïl-Faugeron V, Fron Chabouis H, Durieux P, Attal JP, Muller-Bolla M, Courson F. Development of a core set of outcomes for randomized controlled trials with multiple outcomes: example of pulp treatments of primary teeth for extensive decay in children. PLoS ONE. 2013;8(1):e51908.
doi: 10.1371/journal.pone.0051908
Smaïl-Faugeron V, Courson F, Durieux P, Muller-Bolla M, Glenny AM, Fron Chabouis H. Pulp treatment for extensive decay in primary teeth. Cochrane Database Syst Rev. 2014;8:CD003220.
Smaïl-Faugeron V, Glenny AM, Courson F, Durieux P, Muller-Bolla M, Fron Chabouis H. Pulp treatment for extensive decay in primary teeth. Cochrane Database Syst Rev. 2018;5:CD003220.
pubmed: 29852056
Stringhini Junior E, Dos Santos MGC, Oliveira LB, Mercadé M. MTA and biodentine for primary teeth pulpotomy: a systematic review and meta-analysis of clinical trials. Clin Oral Investig. 2019;23(4):1967–76.
doi: 10.1007/s00784-018-2616-6
Suresh K. An overview of randomization techniques: an unbiased assessment of outcome in clinical research. J Hum Reprod Sci. 2011;4(1):8–11.
doi: 10.4103/0974-1208.82352
Vilimek VM, Gateva N, Christof BS. Success rate of MedCem Portland cement as a pulp capping agent in pulpotomies of primary teeth. J IMAB. 2018;24(1):1866–71.
doi: 10.5272/jimab.2018241.1866
Waterhouse PJ, Nunn JH, Whitworth JM. An investigation of the relative efficacy of Buckley’s formocresol and calcium hydroxide in primary molar vital pulp therapy. Br Dent J. 2000;188(1):32–6.
doi: 10.1038/sj.bdj.4800380
Waterhouse PJ. “New age” pulp therapy: Personal thoughts on a hot debate. Pediatr Dent. 2008;30(3):247–52.
pubmed: 18615991